Investigation Overview
April 24, 2015 (Shareholders Foundation) - An investigation on behalf of investors of Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares over potential securities laws violations by Aerie Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of ...
You must register (for free) or login to view the entire investigation.